UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045864
Receipt number R000052354
Scientific Title Investigation for recovery of fatigue by ingestion of Amazake in Futsal player, randomized cross-over study
Date of disclosure of the study information 2021/10/26
Last modified on 2023/11/20 12:44:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effects of Amazake ingestion on recovery of fatigue in Futsal player

Acronym

Effects of Amazake ingestion on recovery of fatigue in athletes

Scientific Title

Investigation for recovery of fatigue by ingestion of Amazake in Futsal player, randomized cross-over study

Scientific Title:Acronym

Recovery of fatigue by ingestion of Amazake

Region

Japan


Condition

Condition

Healthy athletes

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of Amazake ingestion on recovery from fatigue

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in serum and saliva hormone after the ingestion for 3 weeks

Key secondary outcomes

Subjective fatigue


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Ingestion of test drink for 3 weeks/ washout period for 2 weeks/ Ingestion of placebo drink for 3 weeks

Interventions/Control_2

Ingestion of placebo drink for 3 weeks/ washout period for 2 weeks/ Ingestion of test drink for 3 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male

Key inclusion criteria

Professional or semiprofessional Futsal player

Key exclusion criteria

Can not drink Amazake

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Kazuko
Middle name
Last name Ishikawa-Takata

Organization

Tokyo University of Agriculture

Division name

Faculty of Applied Bioscience

Zip code

1568502

Address

1-1-1 Sakuragaoka, Setagaya Tokyo,Japan

TEL

81-3-5477-2453

Email

kt207460@nodai.ac.jp


Public contact

Name of contact person

1st name Kazuko
Middle name
Last name Ishikawa-Takata

Organization

Tokyo University of Agriculture

Division name

Faculty of Applied Bioscience

Zip code

1568502

Address

1-1-1 Sakuragaoka, Setagaya Tokyo,Japan

TEL

81-3-5477-2453

Homepage URL


Email

kt207460@nodai.ac.jp


Sponsor or person

Institute

Tokyo University of Agriculture

Institute

Department

Personal name



Funding Source

Organization

Tokyo University of Agriculture

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo University of Agriculture, The Ethical Committee of Experiment and Survey for Human

Address

1-1-1 Sakuragaoka, Setagaya Tokyo,Japan

Tel

81-3-5477-2532

Email

t3tanaka@nodai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 10 Month 12 Day

Date of IRB

2021 Year 10 Month 12 Day

Anticipated trial start date

2021 Year 10 Month 13 Day

Last follow-up date

2021 Year 12 Month 17 Day

Date of closure to data entry

2022 Year 08 Month 31 Day

Date trial data considered complete

2023 Year 01 Month 31 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 26 Day

Last modified on

2023 Year 11 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052354